Research published in Nature Communications showed how specific cells in the lungs switch between two essential functions. Elas cannot repair damage and fight infection at the same time. The finding could influence treatments for conditions such as pulmonary fibrosis and chronic obstructive pulmonary disease.
The researchers tracked the behavior of type 2 alveolar cells. Essas cells produce substances that keep the alveoli open. Elas also act as precursors to replace damaged cells at the surface where oxygen exchange occurs.
Células type 2 alveolar cells act as a regeneration reservoir
Type 2 alveolar cells, known as AT2, form a versatile group in lung tissue. Elas secrete surfactant proteins that prevent air sacs from collapsing during respiration. Além also serve as local stem cells capable of generating new type 1 alveolar cells, AT1, responsible for the thin barrier that allows the passage of oxygen into the blood.
In healthy lungs, this system maintains balance. Quando an injury occurs, part of the AT2 needs to change its behavior to begin repair. The process involves a temporary transition that allows lost cells to be replaced.
The team used single-cell sequencing and laboratory injury models. The results indicated that newly formed AT2 cells maintain flexibility for about one to two weeks. Depois of this period, they specialize and lose part of this capacity.
- AT2 produce surfactant to keep alveoli open
- Elas function as precursors to generate damaged AT1
- The repair transition occurs after release of control mechanisms
- In chronic diseases, the balance between functions is impaired
Molecular Mecanismo decides priority between repair and defense
The circuit that governs this choice involves three main components. The PRC2 complex, the C/EBPα protein, and DLK1 work together to time cell behavior. C/EBPα functions as a kind of lock that limits the regenerative activity of AT2 under normal conditions.
Quando adult lung damage occurs, this lock needs to be loosened for repair to progress. The same mechanism influences whether the cell prioritizes immune defense or tissue reconstruction. Durante infections, the protective response takes priority and repair takes a backseat.
Essa division explains why recovery takes longer in patients with chronic lung diseases. Tissue cannot regenerate efficiently while the immune system remains activated. The researchers observed similar patterns in experimental injury models.
The study followed the complete cell cycle from development to adulthood. Advanced Imagens and genetic analyzes helped map changes in real time.
Interrupted Equilíbrio explains difficulty in recovering from illness
Pacientes with pulmonary fibrosis, COPD or severe sequelae of viral infections face weakened regeneration. The new work suggests that the imbalance in molecular control contributes to this situation. Quando cells become trapped in defense mode, the tissue accumulates scars or loses functionality.
The research highlighted that adult AT2s need to temporarily recover stem cell characteristics after injury. Sem This means that the lung does not restore its original spongy structure. The finding reinforces long-standing observations by the scientific community about the limitation of repair in adults.
The authors followed cells at different stages. Eles noted that plasticity decreases as time passes after the initial formation of AT2.
Descoberta points to targets for new therapeutic approaches
The results open possibilities for interventions that modulate C/EBPα activity. Estratégias that help release the molecular lock could improve the repair capacity of AT2 cells. Isso would include scar reduction in fibrosis or support for regeneration in emphysema.
Especialistas also mention the potential for biomarkers to identify early when cells become locked into a single mode. Testes in the laboratory are already exploring safe ways to adjust this mechanism in human cells.
Pulmonologist Banu Altoparlak commented on the future impact. Ela highlighted the potential to reverse chronic processes in diseases that affect the lung structure and lead to respiratory failure. Early Intervenções could preserve patients’ quality of life.
Qualquer clinical application still requires years of trials and regulatory approvals. The team emphasizes the need for caution to avoid side effects when manipulating cellular control.
Estudo details circuit that regulates plasticity of AT2 cells
The work combined multiple techniques to construct the complete picture. Single cell Sequenciamento, advanced imaging, and damage model experiments formed the basis of the analysis. The researchers published the findings in Nature Communications in October 2025.
Douglas Brownfield, lead author, led the research in Mayo Clinic’s lung development and regeneration laboratory. The team observed that the circuit forms a pulse generator that controls DLK1 expression via suppression of Notch signaling.
Esse mechanism creates a mixed pattern of cells with different destinations. Algumas undertake repair while others maintain defense functions. The discovery helps explain why the adult lung has limited capacity for regeneration compared to earlier stages of life.